Skip to main content

Advertisement

Table 1 Clinical characteristics of patients at baseline

From: Advanced Practice Pharmacists: a retrospective evaluation of the efficacy and cost of ClinicaL Pharmacist PractitionErs managing ambulatory Medicare patients in North Carolina (APPLE-NC)

  CPP (n = 65) PCP (n = 65)  
Mean 95 % CI Mean 95 % CI p-value
BMI 31.2 29.4–33.0 31.0 29.3–32.6 0.85
Average 10 year CVD risk 23.3 18.1–28.5 22.7 17.8–27.7 0.80
Systolic Blood Pressure Average 132.4 127.3–137.5 136.6 131.2–142.0 0.27
Total Cholesterol 184.2 169.4–199.0 182.4 168.0–196.8 0.86
High Density Lipoprotein 51.2 46.6–55.8 53.3 48.2–58.3 0.55
Hemoglobin A1c 7.5 6.8–8.2 6.8 6.2–7.3 0.02
Brief Pain Inventory Score 7.2 6.2–8.2 6.5 5.0–8.0 0.37
Outpatient Visitsa 20.6 18.2–22.9 13.2 10.5–15.9 0.0002
Primary Care Provider Visits 15.0 12.9–17.1 13.2 10.5–15.9 0.32
Clinical Pharmacist Practitioner Visitsb 5.6 4.6–6.7 0 N/A N/A
Emergency Department Visitsc 1.7 1.2–2.3 2.9 1.7–4.1 0.06
Emergency Department Visits related to HTN, DM, Paind 0.25 0.1–0.4 0.52 0.10–0.95 0.20
Inpatient Admissionse 1.4 0.8–1.9 1.8 1.0–2.6 0.32
Inpatient Admissions related to HTN, DM, Painf 0.5 0.1–0.9 0.4 0.2–0.5 0.51
  1. aTotal outpatient visits: CPP cohort 1338 visits; PCP cohort 858 visits
  2. bPatients in the PCP cohort did not receive treatment from CPPs, therefore, there were no CPP visits in the PCP, and a p-value was unable to be calculated
  3. cEmergency Department visits: CPP 115 ED visits; PCP 190 ED visits
  4. dEmergency Department visits related to HTN, DM, Pain: CPP 16 ED visits; PCP 34 ED visits
  5. eInpatient Admissions: CPP 88 IA; PCP 117 IA
  6. fInpatient Admissions related to HTN, DM, Pain: CPP 32 IA; PCP 23 IA